Dr. Tyler John Michael Mills, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 571 Haddon Ave, Collingswood, NJ 08108 Phone: 856-858-3937 |
Dr. Brian C Samartino, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 571 Haddon Ave, Collingswood, NJ 08108 Phone: 856-858-3937 Fax: 856-425-2571 |
Marlee Silversmith, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 571 Haddon Ave, Collingswood, NJ 08108 Phone: 856-858-3937 |
Premier Eye Senior Care, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 571 Haddon Ave, Collingswood, NJ 08108 Phone: 856-858-3937 Fax: 856-425-2571 |
Karen Levy, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 900 Haddon Ave Ste 102, Collingswood, NJ 08108 Phone: 856-854-4242 Fax: 856-854-3585 |
Dr. Alisha M Kothari, OD Optometrist Medicare: Medicare Enrolled Practice Location: 571 Haddon Ave, Collingswood, NJ 08108 Phone: 856-858-3937 Fax: 856-425-2571 |
Premier Eye Associates Optometrist Medicare: Medicare Enrolled Practice Location: 571 Haddon Ave, Collingswood, NJ 08108 Phone: 856-858-3937 Fax: 856-425-2571 |
News Archive
Federal stimulus funding is helping a Kansas State University biologist continue to collaborate with the Harvard Medical School. Their research is creating a clearer picture of a certain cellular process that can play a role in chronic diseases like cancer.
The most advanced noninvasive, radiosurgery tool for treating a variety of brain disorders-including tumors-is now being used by specialists at UCSF Medical Center.
The Cancer Patient Education Network (CPEN) honored the Patient Education Team from Penn Medicine's OncoLink with the 2018 Excellence in Patient Education Award.
Despite the fact that symptomatic coronary disease afflicts men and women equally, only 33 percent of the 1.2 million interventional procedures conducted in the U.S. each year are done on women.
Researchers at Trinity College Dublin have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target.
› Verified 8 days ago